Compare PAHC & ELE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PAHC | ELE |
|---|---|---|
| Founded | 1946 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2014 | 2025 |
| Metric | PAHC | ELE |
|---|---|---|
| Price | $35.90 | $15.55 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $47.00 | $28.67 |
| AVG Volume (30 Days) | 188.0K | ★ 327.2K |
| Earning Date | 11-04-2026 | 11-10-2026 |
| Dividend Yield | ★ 1.22% | 0.58% |
| EPS Growth | ★ 104.20 | N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | ★ $833,350,000.00 | N/A |
| Revenue This Year | $3.91 | $105.74 |
| Revenue Next Year | $3.48 | $24.81 |
| P/E Ratio | ★ $16.23 | $255.64 |
| Revenue Growth | ★ 4.12 | N/A |
| 52 Week Low | $28.25 | $14.01 |
| 52 Week High | $60.08 | $26.96 |
| Indicator | PAHC | ELE |
|---|---|---|
| Relative Strength Index (RSI) | 58.19 | 40.76 |
| Support Level | $32.97 | $14.52 |
| Resistance Level | $40.76 | $17.21 |
| Average True Range (ATR) | 1.35 | 0.56 |
| MACD | -0.09 | -0.02 |
| Stochastic Oscillator | 60.33 | 45.48 |
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
Elemental Royalty Corp is engaged in exploration discovery, royalty generation, royalty acquisition, and strategic investments. It is the result of the strategic merger of Elemental Altus Royalties and EMX Royalty Corporation together creating a mid-tier gold-focused royalty company with the scale, diversification, and cash flow. Geographically, the company generates revenue from North America, South America, Europe, Australia and Africa.